In 2023, the REF-11 project was carried out to assess the compliance of safety data sheets (SDS) with the new requirements introduced by Regulation (EU) 2020/878. Key changes included mandatory information on nanoforms, endocrine-disrupting properties, and other relevant data, such as acute toxicity (ATE), specific concentration limits (SCL), and environmental multiplication factors (M-factor).
Out of the 2,528 SDS examined, the non-compliance rate was 35%, showing an improvement compared to previous projects. However, some information was found to be missing during the review, particularly in sections related to nanoforms and endocrine disrupting properties.